At Virginia Cancer Specialists, research isn’t just a part of what we do — it’s the cornerstone of our mission to provide the best available care for every patient.
With +200 active clinical trials across Phase 1-3, we’re proud to offer patients access to innovative investigational therapies – often unavailable to the general public. From early-phase studies to later-stage trials, our programs are designed to address nearly every type of cancer and mutation.
Through our dedicated Research Institute and joint venture with NEXT Oncology, we’ve built the largest and most comprehensive oncology research program in the Mid-Atlantic Region – with patients traveling from across the U.S., Europe, and South America to be part of this work.
In 2023 alone, we enrolled 440 patients, supported by a team of 150+ research professionals committed to advancing cancer care.
Innovation. Access. Hope. This is the future of oncology – and it’s happening here. Learn More HERE
